KENNEWICK, Wash., March 14, 2011 (GLOBE NEWSWIRE) -- James Katzaroff, Chairman and Chief Executive Officer of Advanced Medical Isotope Corporation (OTCBB:ADMD), a company engaged in the production and distribution of medical isotopes, will participate in the "Success Story" panel discussion at the United States Industry Coalition (USIC) Annual Meeting to be held March 15-17 at the offices of Pillsbury Winthrop Shaw Pittman in Washington, DC. The panel will convene on the afternoon of Wednesday, March 16.
In addition to Advanced Medical Isotope Corporation, the panel will include presentations by two other USIC members, DuPont and Campbell Applied Physics. The participants will explain how their USIC GIPP partnerships have developed and are bringing them success. GIPP is a proven model for technology commercialization involving partnerships among U.S. industry, U.S. national laboratories, and Russian and other former Soviet scientific institutes.
Mr. Katzaroff said, "Participating in this USIC panel discussion helps spread the word about Advanced Medical Isotope Corporation's innovations in the medical isotope sector. In response to the ongoing shortage of medical isotopes, we are formulating strategies to dramatically increase production in the U.S. Specifically, we have plans to develop a way to produce molybdenum-99 and other radioisotopes not with a nuclear reactor, but rather with small compact devices."
The theme of the USIC conference is building global partnerships for innovation. Its goal is for individuals and companies to come away with information on opportunities and partnerships that can make a near-term, positive impact on their businesses. The 2010 Annual Meeting attendees included USIC members and potential members, representatives from the Department of Energy and National Labs, Department of Defense, Department of Commerce, BARDA and an array of other Federal agencies. Also attending were foreign dignitaries and business leaders from Saudi Arabia and Russia.
For more information about the annual meeting and the agenda, please visit:
About the United States Industry Coalition (USIC)
The United States Industry Coalition (USIC) is an international, non-profit corporate membership association of high tech businesses and research institutions actively engaged in technology commercialization in the service of global security, peace and prosperity. Through expanding global alliances, USIC helps member companies find cost-effective, international sources of technical expertise and assists in bringing new technologies into the global marketplace.
About Advanced Medical Isotope Corporation
Advanced Medical Isotope Corporation (OTCBB:ADMD) is a company engaged in the production and distribution of medical isotopes for advanced diagnostic and non-surgical therapeutic application. AMIC's goal is to empower physicians, medical researchers, and ultimately patients by providing them with essential medical isotopes that, until recently, have not been feasible or economical, in an effort to detect and cure human disease. For more information, please visit our website, .
The Advanced Medical Isotope Corporation logo is available at
Safe Harbor Statement
The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by the use of the words "may", "will", "should", "plans", "expects", "anticipates", "continue", "estimates", "projects", "intends", and similar expressions. Forward-looking statements involve risks and uncertainties that could cause results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technical advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, government agency rules and changes, and various other factors beyond the Company's control.
CONTACT: Advanced Medical Isotope Corporation James C. Katzaroff (509) 736-4000 The Investor Relations Group 11 Stone St. 3rd Floor New York, NY 212-825-3210 IR: Adam Holdsworth/James Carbonara or PR: Laura Colontrelle/Janet Vasquez